2,30-Bis(10H-indole) heterocycles: New p53/MDM2/MDMX antagonists

Bioorg Med Chem Lett. 2015 Dec 15;25(24):5661-6. doi: 10.1016/j.bmcl.2015.11.019.

Abstract

The protein–protein interaction of p53 and MDM2/X is a promising non genotoxic anticancer target. A rapid and efficient methodology was developed to synthesize the 2,30-bis(10H-indole) heterocyclic scaffold 2 as ester, acid and amide derivatives. Their binding affinity with MDM2 was evaluated using both fluorescence polarization (FP) assay and HSQC experiments, indicating good inhibition and a perfect starting point for further optimizations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Fluorescence Polarization
  • Heterocyclic Compounds / chemical synthesis
  • Heterocyclic Compounds / chemistry*
  • Heterocyclic Compounds / metabolism
  • Indoles / chemistry
  • Molecular Docking Simulation
  • Protein Interaction Domains and Motifs
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins c-mdm2 / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-mdm2 / metabolism
  • Tumor Suppressor Protein p53 / antagonists & inhibitors*
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Heterocyclic Compounds
  • Indoles
  • Tumor Suppressor Protein p53
  • indole
  • Proto-Oncogene Proteins c-mdm2